Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies

Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes. While clinical trials and observational studies have traditionally included DKA events as part of their safety analyses, several studies have looked specifically at the levels of blood β-hydroxybutyrate associated with DKA in both type 1 diabetes (T1D) and type 2 diabetes (T2D) populations. However, in the findings from these studies, all of the reported data on ketone levels were obtained in the presence of elevated glucose levels or DKA symptoms, using episodic ketone testing via urine ketone test strips. In this report, we present findings from a real-world analysis that investigated patterns of blood ketone testing in people with diabetes using the FreeStyle Libre Continuous Glucose Monitoring system. We also report preliminary case studies from a study currently underway that utilizes a novel dual glucose-ketone sensor to elucidate the glucose and ketone variations in a daily life in people with T1D or T2D who are treated with insulin or sodium-glucose transporter-2 inhibitors therapy.

Authors

Institutions

Publication Details

Journal
Diabetes Technology & Therapeutics
Published
2025-11-01
DOI
https://doi.org/10.1177/15209156251390833
Citations
1
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies

Shridhara Alva, Federico Quadri, Richard M. Bergenstal, Naunihal Virdi
1 citations
Diabetes Technology & Therapeutics
Diabetes and associated disorders
1.82
article

Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies

Shridhara Alva, Federico Quadri, Richard M. Bergenstal, Naunihal Virdi
article en
1 citations

Abstract

Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes. While clinical trials and observational studies have traditionally included DKA events as part of their safety analyses, several studies have looked specifically at the levels of blood β-hydroxybutyrate associated with DKA in both type 1 diabetes (T1D) and type 2 diabetes (T2D) populations. However, in the findings from these studies, all of the reported data on ketone levels were obtained in the presence of elevated glucose levels or DKA symptoms, using episodic ketone testing via urine ketone test strips. In this report, we present findings from a real-world analysis that investigated patterns of blood ketone testing in people with diabetes using the FreeStyle Libre Continuous Glucose Monitoring system. We also report preliminary case studies from a study currently underway that utilizes a novel dual glucose-ketone sensor to elucidate the glucose and ketone variations in a daily life in people with T1D or T2D who are treated with insulin or sodium-glucose transporter-2 inhibitors therapy.

Diabetes Technology & TherapeuticsVol. 27(S4)
Diabetes Care Center (US), Abbott Diabetes Care (United States), HealthPartners (US)
Openalex Percentile: Top 11%
Diabetes and associated disorders
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies — Shridhara Alva, Federico Quadri, et al. · Diabetes Technology & Therapeutics (2025) | TGRS Research Map | TGRS